课题基金 / 基金详情

CELLULAR TRANSPLANTATION IN GENETICALLY MODULATED LIVER

CELLULAR TRANSPLANTATION IN GENETICALLY MODULATED LIVER
基因调控肝脏中的细胞移植
批准号:
2887936
负责人:
abraham na shaked
金额:
$26.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-15 至 2001-08-31

项目摘要

项目成果

abraham na shaked的其他基金

相似基金

相关文献

中文摘要
翻译
描述:使用基因转移技术对肝脏进行体细胞调节 是一种技术,允许测试的假设与潜在的应用 在移植环境中。 在这方面,调查人员建议, 如果用序列转导肝脏, 表达能够抑制免疫应答的蛋白质/肽。 在 理论上,转基因肝脏可以作为一种"免疫学上的", 受保护的部位,"能够接受同种异体细胞移植, 排斥反应 在该模型中,抑制免疫应答在细胞内, 天然肝脏将通过表达蛋白质/肽来实现 能够抑制T细胞识别(非多态性MHC肽), 活性(病毒IL-10)或共刺激途径(CTLA4Ig)。 为了验证这一 假设该提案有三个具体目标:1)应用最近和 基因转移技术在肝脏调控中的未来发展 因为它准备成为细胞移植的部位。 使用 新的腺病毒载体构建体允许将 移植环境:最佳表达长度、免疫反应 针对转导的肝细胞,重组抑制剂 蛋白质/肽的产生对转移序列的寿命的影响, 以及将载体表达限制在肝脏的能力; 2)为了遵循 生物学功能,并决定促进生存的条件 移植同种异体肝细胞在调制的天然肝脏。 的 实验将在肝脏相关的临床相关模型中进行。 蛋白质缺陷,并将相关载体表达,生物 移植细胞的功能和同种免疫反应; 3) 在移植环境中应用基因转移技术必须 考虑到抑制外界免疫过程的潜在后果, 被转换的器官 这些研究试图确定 系统免疫和同种免疫的位点特异性抑制之间的关系 反应,并与短期或长期表达的 免疫抑制蛋白/肽与排斥反应,保存 肝外T细胞对标称抗原的应答,以及维持 同源肿瘤的免疫监视。 最终目的是规范 并限制移植器官的免疫抑制。 总之,这 该提案探讨了基因转移技术的应用, 创造允许接受同种异体细胞的受保护环境, 同时保持正常的全身免疫力。
英文摘要
DESCRIPTION: Somatic modulation of the liver using gene transfer technology is a technique which allows testing of hypotheses with potential application in the transplant setting. In this context, the investigators propose that the immune milieu can be modified if livers are transduced with sequences expressing proteins/peptides capable of suppressing the immune response. In theory, genetically modified liver could serve as an "immunologically protected site," able to accept allogeneic cell transplantation without rejection. In this model, inhibition of the immune response within the native liver would be accomplished by expression of proteins/peptides capable of inhibiting T cell recognition (non-polymorphic MHC peptides), activity (viral IL-10), or costimulatory pathways (CTLA4lg). To test this hypothesis the proposal has three specific aims: 1) To apply recent and future developments in gene transfer technology for modulation of the liver as it is prepared to be a site for cellular transplantation. The use of novel adenovirus vector constructs allow correlation of variables unique to the transplant setting: optimal length of expression, immune response against transduced liver cells, the impact of recombinant inhibitor protein/peptide production on the life span of the transferred sequences, and the ability to restrict vector expression to the liver; 2) To follow the biological function and determine conditions which promote survival of transplanted allogeneic hepatocytes in the modulated native liver. The experiments will be performed in clinically-relevant models of liver-related protein deficiency, and will correlate vector expression, biological function of the transplanted cells, and alloimmune response; 3) The application of gene transfer technology in the transplant setting must consider the potential consequences of suppressing immune processes outside the transduced organ. These studies attempt to define the relationship between systemic immunity and site-specific suppression of the alloimmune response, and to correlate short or long term expression of immunosuppressive proteins/peptides with rejection, preservation of extrahepatic T cell response to nominal antigen, and maintenance of immune-surveillance of syngeneic tumors. The ultimate goal is to regulate and restrict immunosuppression to the transplanted organ. In summary, this proposal explores applications of gene transfer techniques which aim to create a protected environment allowing acceptance of allogeneic cells, while maintaining normal systemic immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular profiling and immunomodulatory interventions
  • 批准号:
    6948240
  • 项目类别:
  • 资助金额:
    $287.76万
  • 财政年份:
    2004
  • 负责人:
    abraham na shaked
  • 依托单位:
Molecular profiling and immunomodulatory interventions
  • 批准号:
    7118193
  • 项目类别:
  • 资助金额:
    $284.8万
  • 财政年份:
    2004
  • 负责人:
    abraham na shaked
  • 依托单位:
Molecular profiling and immunomodulatory interventions
  • 批准号:
    6875931
  • 项目类别:
  • 资助金额:
    $230.53万
  • 财政年份:
    2004
  • 负责人:
    abraham na shaked
  • 依托单位:
Molecular profiling and immunomodulatory interventions
  • 批准号:
    7284805
  • 项目类别:
  • 资助金额:
    $278.02万
  • 财政年份:
    2004
  • 负责人:
    abraham na shaked
  • 依托单位:
海外基金